Oncology

Is ddPCR the solution to late genetic results and delayed treatment?

A nurse's experience as a patient gave her a greater appreciation of the overall medical process

Testing ctDNA in the blood could aid in predicting relapse risk for melanoma patients

A higher survival rate and more accurate prognosis may come from testing tiny genetic alterations

Could the tumor-stroma ratio (TSR) yield more accurate reuslts than the tumor-node-metastasis (TMN) system?

Read the tale behind the tumor classification reference books put together by the WHO's IARC

An investigation into PARP1 has given some insight into its link with cancer treatment-resistance

IBM's Watson takes a dive into the field of genomics to look for actionable cancer mutations

Predicting pancreatic lesion malignancy risk is only an assay away with a PCR-based technique

Discontinuing leukemia treatment without cancer recurrence may be a little safer thanks to ddPCR